Navigation Links
Amnis Begins Shipment of New ImageStreamX Imaging Flow Cytometers
Date:10/6/2009

SEATTLE, Oct. 6 /PRNewswire/ -- Amnis Corporation, a manufacturer of advanced cell imaging systems, today announced the first commercial shipments of the new ImageStreamX imaging flow cytometers. The new instrument - the second generation of Amnis' patented ImageStream® technology - combines the speed, sensitivity, and phenotyping abilities of flow cytometry with the detailed imagery, rich feature set, and functional insights of microscopy.

"The ImageStreamX is the result of focused technology development based on both a broad market research study and more than five years of very close work with our customer base," remarked William E. Ortyn, Amnis' co-founder and Chief Operating Officer. "If early market response is a good indicator of ultimate product success, then it appears this work was right on the mark," he added.

"Pre-sales of the ImageStreamX have greatly exceeded our expectations, particularly given the current economic climate," said David Basiji, Ph.D., Amnis' President and Chief Executive Officer. "These sales results are due to the dramatic performance increase combined with the greater affordability and modularity of the new ImageStreamX, which allows the instrument to fit into a much wider range of labs and budgets," explained Basiji. Mr. Ortyn added, "The ImageStreamX has many of the attributes necessary to perform in the clinical market place. Over the next several months we look forward to releasing a wide array of options and applications kits to further enhance product capabilities."

About Amnis: Amnis Corporation, headquartered in Seattle, WA, develops, manufactures and markets instrumentation for high speed cell imaging for research and diagnostic markets. The initial ImageStream system, introduced in 2005, is in service in over 15 countries world-wide, and has an excellent track record of performance and reliability. Researchers have utilized ImageStream technology to produce over 80 groundbreaking publications and numerous conference posters and presentations.

www.amnis.com

SOURCE Amnis Corporation


'/>"/>
SOURCE Amnis Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
2. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
3. Enrollment Begins on Human PK Study for Medidur(TM) FA
4. Vical Begins Phase 1 Trial of DNA Vaccine Against H5N1 Pandemic Influenza
5. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
6. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
7. Metabolex Begins Phase 2 Trial of MBX-8025 for Treatment of Dyslipidemia
8. DiObex Begins Dosing Patients in Phase 2b Trial of Type 2 Diabetes Drug
9. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
10. Dynavax Begins TOLAMBA(TM) Environmental Exposure Chamber Study
11. BiPar Begins Phase 2 Study of Lead PARP Inhibitor in Triple-Negative Breast Cancer Based on Overexpression Biomarker Data
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... , March 29, 2017  Zynex (OTCQB: ZYXI), an innovative ... of non-invasive medical devices for pain management, stroke rehabilitation, ... will host the Company,s 2016 full-year investor webcast on Monday, ... The Company expects to file its 2016 ... ...
(Date:3/29/2017)... , March 29, 2017 According to a new ... Type (Gas-Filled Detectors, Geiger Muller, Survey Meter, Solid-State), Products (Personal Dosimeters, OSL, ... 2021" published by MarketsandMarkets, the market is expected to reach USD 1,215.4 ... of 6.5% from 2016 to 2021. Continue ... ...
(Date:3/29/2017)... WASHINGTON , March 29, 2017  The Pharmaceutical ... regarding a new PhRMA report on patient out-of-pocket spending: ... for Medicare and Medicaid Services (CMS), the average amount ... be 13% of drug spending in 2016, down from ... is a pricing problem, not a coverage problem. Health ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... 2017 , ... During the last week of March, Chad Kawa, MD of ... in the local community. , Colon cancer is the second leading cause of ... while it is small, confined and easier to treat. If you are 50 or ...
(Date:3/29/2017)... ... 2017 , ... In the United States alone, up to 36% of primary ... of metastatic brain tumors(3). Though most meningiomas are benign, metastatic brain tumors are known ... effective treatment options, the San Diego Gamma Knife Center offers a precision-medicine ...
(Date:3/29/2017)... ... March 29, 2017 , ... Full Contact K9, an Atlanta-based ... Pet Protect Law that assists dog owners in creating legally-enforceable pet trusts for ... taking the natural next step to protect their new companion. Says Evan Dunbar, CEO ...
(Date:3/29/2017)... ... March 30, 2017 , ... CHARM CITY RUN WELCOMES ... has announced that Mercy Medical Center will serve as the official title sponsor of ... On Sunday, June 25, 2017, thousands of women will walk or run the course ...
(Date:3/29/2017)... ... March 30, 2017 , ... Sublime Naturals and its founder, Kathy ... "Wonder Spice", it has been used for thousands of years. , "The West has ... author of " Turmeric: How to Use it For Your Wellness. Overcome Inflammation, Enemy ...
Breaking Medicine News(10 mins):